临床研究协调者(CRC)英文全称Clinical Research Coordinator,临床研究协调者。 负责临床试验的落实工作;负责跟踪研究进度及临床试验工作协调,重要的一项是筛选入组患者的数据收集、录入EDC系统等。 主要职责如下: □与伦理委员会和申办者、C...
If there is one soft skill you must master on this list, it's self awareness. As clinical research professionals, we're constantly interacting with variousstakeholders. Before reacting to any situation, you want to be in full control of yourself by beingself-aware. For example, if you are ...
medical expense cash allowance and 4. Role Type: Full-time, permanent 5. Start Date: We are currently recruiting for start dates throughout 2024, which occur on a monthly basis. You will be asked to state your availability on your application form 6. Location: This role is based in oubo...
(Full-Time Equivalent ):工作量 ISA (Investigator Study Agreement ):研究者合同 Generic drug 通用名药 IP-Investigational Product 研究产品 Global assessment variable 全局评价变量 Investigational Site 研究中心 Grade 级别 Labeling 标签 GCP- Good Clinical Practice Laboratory Assessment 实验室评估 LPI/LSI-Last...
CRF（Case Report Form）病例报告表 Categorical variable 分类变量 Cav 平均浓度 CRF- Case Report Form 病例报告表 CL 清除率 Clinical equivalence 临床等效应 CM（Clinical Monitoring/Operation）：临床监查/运营CRA（Clinical Research Associate）：临床监查员CRC（Clinical Research Coordinator）：...
Full size image Moreover, the clinical outcomes of patients in the two subtypes were compared. The K-M plots illustrated that the patients in CS1 had worse prognoses than CS2 (OS: p < 0.0001; DFS: p = 0.00027; Fig. 2F, G). Table 1 shows the demographic features of CRC pati...
However, difference in activity was seen only in PDOs derived from both primary tumor and liver metastases CRC patients, harboring mutations in PI3K and/or RAS-RAF-MAPK pathways. Another main strategy in leveraging the full potential of PDOs, consists in directly using the organoids technology ...
DESTINY-CRC01 (NCT03384940) was a multicenter, open-label, phase 2 trial assessing the efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients with HER2-expressing metastatic colorectal cancer (mCRC) that progressed after ≥2 prior regimens; results of the primary analysis are publishe...
CRC development may take decades to transform into the final form of cancer. Many factors could modify the pace of this process, including diet, alcohol, and tobacco consumption, as well as contaminants present in water and food [5, 6]. Recently, the gut microbiota (GM) has also been ...
Another main strategy in leveraging the full potential of PDOs, consists in directly using the organoids technology in optimizing combinatory treatment strategies for CRC patients. In a recent study conducted by our research team, Ramzy etal. established an innovative platform for the rapid optimizatio...